Remove FDA Remove Healthcare Provider Remove Patients
article thumbnail

FDA drops PreCert report, new digital health guidances

pharmaphorum

The US FDA’s Center for Devices and Radiological Health (CDRH) dropped a bevy of new digital health guidances and reports today and yesterday, providing some long-awaited clarity and peeks into the agency’s future plans. . The push started yesterday with the 31-page key findings report from the FDA Pre-Certification Program pilot.

FDA 135
article thumbnail

What Pear Therapeutics’ Bankruptcy Has Left the DTX Industry to Ponder

MedCity News

The goal was simple: provide access and focused support to patients remotely while simultaneously relieving overtaxed healthcare facilities. Combined, DTx and DCTs improve patient recruitment, retention, and access, allowing researchers to pull from underserved communities, including rural populations.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

US FDA approves Blueprint Medicines’ indolent systemic mastocytosis therapy

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted approval for Blueprint Medicines’ Ayvakit (avapritinib) as the first and only treatment for indolent systemic mastocytosis (ISM) in adult patients. In addition, Ayvakit is the only treatment approved across the spectrum of indolent and advanced systemic mastocytosis.

article thumbnail

Pharmaceutical Advertising: Strategies and Insights for Effective Pharma Marketing

Pharma Marketing Network

Understanding Your Audience: Different audiencespatients, healthcare professionals, or payersrequire tailored messages. For instance, while patients prioritize benefits and side effects, healthcare providers look for clinical evidence and efficacy. How can you ensure your strategy stands out?

article thumbnail

10 Innovative Trends in Pharma Marketing: Strategies for Industry Success in 2025

Pharma Marketing Network

As we approach 2025, emerging trends are reshaping how the industry engages with patients and healthcare providers. With advancements in technology, increasing competition, and changing patient expectations, pharma marketers need to stay ahead of the curve. Patient-Centric Marketing Patients want to feel heard.

article thumbnail

ResApp bags FDA okay for sleep apnoea app, after Pfizer takeover bid

pharmaphorum

Pfizer is still waiting for the green light to complete an acquisition of digital health company ResApp, a deal that looks even better now that its smartphone app for people with obstructive sleep apnoea (OSA) has been approved by the FDA. The post ResApp bags FDA okay for sleep apnoea app, after Pfizer takeover bid appeared first on.

FDA 105
article thumbnail

Mastering Pharmaceutical Marketing: Strategies to Drive Success in the Pharma Industry

Pharma Marketing Network

Are you targeting healthcare providers (HCPs), patients, or payers? Craft a Patient-Centric Approach Todays consumers want more than medication; they want solutions. For instance, campaigns for branded drugs like Lipitor and Jardiance have gained traction by focusing on patients real-life experiences.